Status:

RECRUITING

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Lead Sponsor:

Pfizer

Collaborating Sponsors:

Genmab

Conditions:

Cervical Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

TIVDAK is used for the treatment of cervical cancer that has come back after chemotherapy. Chemotherapy is a treatment that uses medicines to stop the growth of cancer cells. This is done either by ki...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Must have recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
  • Treating physician has determined that treatment with Tivdak is appropriate for the participant according to US Prescribing Information
  • Must sign an informed consent form indicating that the participant understands the purpose and procedures required for the study and are willing to participate
  • Must be willing to undergo repeated ocular assessments as required by the study and regular clinic visits according to local standard practice of the study site
  • Must agree to use effective contraception according to the US Prescribing Information
  • Exclusion criteria:
  • Active ocular disease at baseline per investigator assessment
  • Previous treatment with Tivdak
  • Previous administration of an investigational drug within 30 days
  • Any medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may, in the investigator'

Exclusion

    Key Trial Info

    Start Date :

    May 7 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 13 2028

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT06952660

    Start Date

    May 7 2025

    End Date

    December 13 2028

    Last Update

    December 12 2025

    Active Locations (42)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 11 (42 locations)

    1

    Mount Sinai Comprehensive Cancer Center - Aventura

    Aventura, Florida, United States, 33180

    2

    Broward Health Coral Springs

    Coral Springs, Florida, United States, 33065

    3

    Broward Health North

    Deerfield Beach, Florida, United States, 33064

    4

    Broward Health Imperial Point

    Fort Lauderdale, Florida, United States, 33308

    Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer | DecenTrialz